A LONGITUDINAL STUDY OF BIOCHEMICAL VARIABLES IN WOMEN AT RISK OF PRE-ECLAMPSIA AND ROLE OF SEROTONIN
Main Article Content
Keywords
Preeclampsia, Biochemical markers, High-risk pregnancy
Abstract
Background: A multi-system disorder that typically occurs after 20 weeks of pregnancy in a woman with normal blood pressure previously is called preeclampsia. In preeclampsia patient suffer from new-onset hypertension and proteinuria.
Objective: To evaluate the variations in key biochemical variables in women at risk of preeclampsia and to investigate the specific role of serotonin in the onset and progression of this disorder.
Methodology: This prospective longitudinal study was conducted at Swat Medical College and its affiliated Hospitals from January 2022 to January 2023. A total of 195 pregnant women, deemed high-risk for preeclampsia based on clinical history and initial screening, were recruited for the study. At the initial visit (first trimester), demographic data and medical histories were recorded. Blood pressure measurements were taken and blood samples were collected for baseline biochemical analyses. Participants underwent scheduled follow-up visits in the second trimester and third trimester. At each visit, blood pressure was monitored, and additional blood samples were collected to measure biochemical variables of interest.
Results: There is an increase observed in soluble fms-like tyrosine kinase-1 (sFlt-1) which may indicate heightened endothelial dysfunction as there is progression in pregnancy. There s a gradual increase in levels of uric acid and creatinine which reflects renal stress commonly associated with advancing gestation. Rise in levels of serotonin in increments throughout trimesters suggests a progressive physiological adaptation or potential role in vascular regulation during pregnancy.
Conclusion: Our study contributes to the understanding of biochemical dynamics specifically highlighting the role of PlGF, sFlt-1, uric acid, creatinine and serotonin in the progression of preeclampsia. Hence these biomarkers are very important in the early diagnosis and treatment of those pregnant women who are at risk of developing preeclampsia thus contributing to the understanding of pathophysiology of the condition along with helping in development of targeted therapeutic strategy.
References
2. Qu H, Khalil RA. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia. American Journal of Physiology-Heart and Circulatory Physiology. 2020 Sep 1;319(3):H661-81.
3. Fu R, Li Y, Li X, Jiang W. Hypertensive Disorders in Pregnancy: Global Burden from 1990 to 2019, Current Research Hotspots and Emerging Trends. Current Problems in Cardiology. 2023 Jul 20:101982.
4. Page JM, Blue NR, Silver RM. Fetal growth and stillbirth. Obstetrics and Gynecology Clinics. 2021 Jun 1;48(2):297-310.
5. Roberts JM, Rich-Edwards JW, McElrath TF, Garmire L, Myatt L, Global Pregnancy Collaboration. Subtypes of preeclampsia: recognition and determining clinical usefulness. Hypertension. 2021 May;77(5):1430-41.
6. Leaños-Miranda A, Graciela Nolasco-Leanos A, Ismael Carrillo-Juarez R, Jose Molina-Perez C, Janet Sillas-Pardo L, Manuel Jimenez-Trejo L, et al. Usefulness of the sFlt-1/PlGF (soluble fms-like tyrosine kinase-1/placental growth factor) ratio in diagnosis or misdiagnosis in women with clinical diagnosis of preeclampsia. Hypertension. 2020 Sep;76(3):892-900.
7. Freire VA, de Melo AD, de Lima Santos H, Barros-Pinheiro M. Evaluation of oxidative stress markers in subtypes of preeclampsia: A systematic review and meta-analysis. Placenta. 2023 Feb 1;132:55-67.
8. Hofmann F. Smooth muscle tone regulation. InEncyclopedia of Molecular Pharmacology 2022 Jan 7 (pp. 1445-1450). Cham: Springer International Publishing.
9. Abad C, Karahoda R, Kastner P, Portillo R, Horackova H, Kucera R, Nachtigal P, Staud F. Profiling of tryptophan metabolic pathways in the rat fetoplacental unit during gestation. International Journal of Molecular Sciences. 2020 Oct 14;21(20):7578.
10. Hitzerd E, Broekhuizen M, Neuman RI, Colafella KM, Merkus D, Schoenmakers S,et al. Human placental vascular reactivity in health and disease: implications for the treatment of pre-eclampsia. Current Pharmaceutical Design. 2019 Feb 1;25(5):505-27.
11. Fournier SB, D’Errico JN, Stapleton PA. Uterine vascular control preconception and during pregnancy. Comprehensive Physiology. 2021 Jun 6;11(3):1871.
12. Perić M, Bečeheli I, Čičin-Šain L, Desoye G, Štefulj J. Serotonin system in the human placenta–the knowns and unknowns. Frontiers in Endocrinology. 2022 Dec 1;13:1061317.
13. Rosenfeld CS. Placental serotonin signaling, pregnancy outcomes, and regulation of fetal brain development. Biology of reproduction. 2020 Mar 13;102(3):532-8.
14. Zhu X, Chen L, Li R. Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients. Clinical and Experimental Hypertension. 2020 Oct 2;42(7):601-7.
15. Stepan H, Galindo A, Hund M, Schlembach D, Sillman J, Surbek D, Vatish M. Clinical utility of sFlt‐1 and PlGF in screening, prediction, diagnosis and monitoring of pre‐eclampsia and fetal growth restriction. Ultrasound in Obstetrics & Gynecology. 2023 Feb;61(2):168-80.
16. Rana S, Burke SD, Karumanchi SA. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. American journal of obstetrics and gynecology. 2022 Feb 1;226(2):S1019-34.
17. Santoyo JM, Noguera JA, Avilés F, Delgado JL, de Paco-Matallana C, Pérez V, Hernández I. Factors involved in endothelial dysfunction related to angiogenic disbalance and oxidative stress, in women at high risk of term pre-eclampsia. Antioxidants. 2022 Jul 21;11(7):1409.
18. Khaliq OP, Konoshita T, Moodley J, Naicker T. The role of uric acid in preeclampsia: is uric acid a causative factor or a sign of preeclampsia?. Current hypertension reports. 2018 Sep;20:1-9.
19. Tesfa E, Munshea A, Nibret E, Mekonnen D, Sinishaw MA, Gizaw ST. Maternal serum uric acid, creatinine and blood urea levels in the prediction of pre-eclampsia among pregnant women attending ANC and delivery services at Bahir Dar city public hospitals, northwest Ethiopia: A case-control study. Heliyon. 2022 Oct 1;8(10).
20. Gumusoglu S, Scroggins S, Vignato J, Santillan D, Santillan M. The serotonin-immune axis in preeclampsia. Current hypertension reports. 2021 Jul;23:1-0.
21. Serena G, Scroggins S, Vignato J, Santillan D, Santillan M. The Serotonin-Immune Axis in Preeclampsia. Current Hypertension Reports. 2021 Jul 1;23(7).
22. Lange KS, Tuloup G, Duflos C, Gobron C, Burcin C, Corti L, Roos C, Ducros A, Mawet J. Complications of reversible cerebral vasoconstriction syndrome in relation to age. Journal of Neurology. 2023 Jul;270(7):3584-94.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Nazish Sadiq
Lecturer, Department of Biochemistry, Rehman College of Dentistry, Peshawar, Pakistan
Dr Chaman Ara
Assistant Professor, Obstetrics & Gynaecology Department, Women Medical College, Abbottabad, Pakistan
Dr Shamaila Wadud
Associate Professor, Department of Biochemistry, Peshawar Medical College, Peshawar, Pakistan
Dr Munaza Khattak
Associate Professor Department of Physiology, Peshawar Medical College, Warsak Road Peshawar, Pakistan
Dr Sajid Khan
Department of Biochemistry, Jinnah Medical College, Peshawar, Pakistan
Dr Aurangzeb Khan
Associate Professor, Department of Pathology, Swat Medical College, Saidu Shareef, Swat, Pakistan